Palonosetron Associated to Aprepitant in Prophylaxis of PONV
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate if aprepitant in association with palonosetron
and dexamethasone could reduce the incidence of PONV in high-risk patients for this symptom,
undergoing cancer surgery mastectomies.